PAVM - PAVmed Inc.

9
-0.170   -1.889%

Share volume: 14,246
Last Updated: 04-24-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 0.00%

PREVIOUS CLOSE
CHG
CHG%
$9.17
-0.17
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
47%
Profitability 50%
Dept financing 25%
Liquidity 7%
Performance 60%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-4.66%
1 Month
-3.23%
3 Months
-3.64%
6 Months
1,909.38%
1 Year
1,084.21%
2 Year
408.47%
Key data
Stock price
$9.00
P/E Ratio 
0.00
DAY RANGE
$9.00 - $9.20
EPS 
$0.39
52 WEEK RANGE
$0.21 - $28.44
52 WEEK CHANGE
$1,150.00
MARKET CAP 
9.453 M
YIELD 
N/A
SHARES OUTSTANDING 
29.672 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-12-2025
BETA 
1.25
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$11,827
AVERAGE 30 VOLUME 
$12,510
Company detail
CEO: Lishan Aklog
Region: US
Website: pavmed.com
Employees: 90
IPO year: 2016
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE)

Recent news